TFF Pharmaceuticals, Inc.
TFFP · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $734 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $502 | $388 | $111 | $0 |
| Gross Profit | $231 | -$388 | -$111 | $0 |
| % Margin | 31.5% | – | – | – |
| R&D Expenses | $11,559 | $18,496 | $21,301 | $10,682 |
| G&A Expenses | $10,567 | $13,796 | $10,574 | $8,012 |
| SG&A Expenses | $10,567 | $13,796 | $10,574 | $8,012 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$496 | -$88 | $0 |
| Operating Expenses | $22,126 | $31,797 | $31,787 | $18,694 |
| Operating Income | -$21,895 | -$31,797 | -$31,787 | -$18,694 |
| % Margin | -2,983.4% | – | – | – |
| Other Income/Exp. Net | $651 | $27 | $748 | $126 |
| Pre-Tax Income | -$21,243 | -$31,770 | -$31,039 | -$18,567 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21,243 | -$31,770 | -$30,987 | -$18,441 |
| % Margin | -2,894.7% | – | – | – |
| EPS | -11.85 | -26.49 | -31.21 | -22.57 |
| % Growth | 55.3% | 15.1% | -38.3% | – |
| EPS Diluted | -11.85 | -26.49 | -31.21 | -22.57 |
| Weighted Avg Shares Out | 1,793 | 1,199 | 993 | 817 |
| Weighted Avg Shares Out Dil | 1,793 | 1,199 | 993 | 817 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $27 | $51 | $126 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $502 | $388 | $111 | $206 |
| EBITDA | -$20,741 | -$31,409 | -$30,927 | -$18,694 |
| % Margin | -2,826.2% | – | – | – |